menu
    • menu

    Company profile for NeuroTrauma Sciences

    NEW Drugs in Dev: 2
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NeuroTrauma Sciences (NTS), founded in 2016, is a biopharmaceutical company developing novel therapeutics for the treatment of CNS injury, with a focus on stroke and traumatic brain injury (TBI). Millions of patients worldwide suffering from lifelong stroke or TBI injuries have limited therapeutic options to alleviate their cognitive, neuromotor, and neurobehavioral deficits. This massively underserved population drives our fo...
    NeuroTrauma Sciences (NTS), founded in 2016, is a biopharmaceutical company developing novel therapeutics for the treatment of CNS injury, with a focus on stroke and traumatic brain injury (TBI). Millions of patients worldwide suffering from lifelong stroke or TBI injuries have limited therapeutic options to alleviate their cognitive, neuromotor, and neurobehavioral deficits. This massively underserved population drives our focused efforts to revolutionize treatments. NTS is developing neuroprotective, anti-inflammatory small molecules that modify injury-induced cell death and dysfunction.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NeuroTrauma SciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2655 Northwinds Parkway, Suite 5C Alpharetta, GA 30009
    Telephone
    Telephone
    +1 833 278 2888
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://neurotraumasciences.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/neurotrauma-sciences-llc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NeuroTrauma Appoints William Fricker, CPA, MBA, as Chief Financial Officer
    NeuroTrauma Appoints William Fricker, CPA, MBA, as Chief Financial Officer

    09 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neurotrauma-sciences-appoints-william-fricker-cpa-mba-as-chief-financial-officer-302029049.html

    PR NEWSWIRE
    09 Jan 2024
    Share Share
    NeuroTrauma Sciences Appoints Kevin Pong, PhD, MBA as Chief Business Officer
    NeuroTrauma Sciences Appoints Kevin Pong, PhD, MBA as Chief Business Officer

    31 Jul 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neurotrauma-sciences-appoints-kevin-pong-phd-mba-as-chief-business-officer-301887676.html

    PR NEWSWIRE
    31 Jul 2023
    Share Share
    NeuroTrauma Sciences Commences First-in-Human Dosing in the US of NTS-104
    NeuroTrauma Sciences Commences First-in-Human Dosing in the US of NTS-104

    01 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neurotrauma-sciences-commences-first-in-human-dosing-in-the-us-of-investigational-neuroprotective-drug-nts-104-301839148.html

    PR NEWSWIRE
    01 Jun 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search